Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Argo Medical And Ekso Bionics Make Strides With Robotic Walking Devices

Executive Summary

Two emerging companies – Argo Medical Technologies Inc. and Ekso Bionics Inc. – are making substantial headway with robotic devices designed to help paralyzed patients regain the ability to walk.

You may also be interested in...

Ekso Bionics Plans 510(k) For Robotic Exoskeleton Based On FDA Class II Designation

The firm will submit a 510(k) later this month for its Ekso GT robotic skeleton, currently being marketed as a class I exempt device, based on feedback from FDA that robotic exoskeleton devices need to meet class II requirements.

FDA OKs First Personal Exoskeleton System To Help Paraplegics Walk

ReWalk Robotics' ReWalk personal exoskeleton system gained FDA market go-ahead June 26. It’s a wearable, motorized device that allows paraplegics with some spinal cord injuries to walk.

High-Tech Solutions For Stroke Rehab

Clinicians who work with stroke patients are beginning to look at robotics and other innovative technologies in rehabilitation that could allow for more treatments without increasing staffing. Young companies with products in development compete with established players in this market, which eventually could become more important to providers as reform efforts move ahead.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts